Biogen defends contentious $56,000 Alzheimer’s drug

Pharma group blames ‘misinformation’ for overshadowing approval of therapy

Source: FT.com - Drugs and Healthcare - July 22, 2021 Category: Pharmaceuticals Source Type: news